This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (3491) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1745) Apps, Mobile, Wearables for Diabetes (366) Diabetes Self-Management (595) Peer-to-Peer Support and Online Communities (803) Health Coaching for Diabetes Patients (176)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68648, first published .
Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial

Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial

Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial

Authors of this article:

Maxi Pia Bretschneider1 Author Orcid Image ;   Agnieszka Barbara Kolasińska2 Author Orcid Image ;   Lenka Šomvárska2 Author Orcid Image ;   Jan Klásek2 Author Orcid Image ;   Jan Mareš2 Author Orcid Image ;   Peter EH Schwarz1, 3, 4 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Bartsch V, Knitza J. Digitale Gesundheitsanwendungen. Zeitschrift für Rheumatologie 2025;84(10):798 View
  2. af Geijerstam P, Johansson E, Fägerstam S, Wu J, Ghafouri B, Karlsson K, Hebib L, Kastbom L, Wennberg P, Gustafson Hedov E, Storgärds M, Sundström J, Rådholm K. Effect of the FoodSwitch application on type 2 diabetes in Sweden: a study protocol for the randomised controlled DIgitAl diabeTES Treatment – the Healthy Eating, heaLthy Patients trial (DIATEST-HELP). BMJ Open 2025;15(11):e110141 View
  3. Roth L, Bretschneider M, Schwarz P. Randomized controlled trial to evaluate an app-based multimodal digital intervention for people with type 2 diabetes in comparison to a placebo app. Frontiers in Digital Health 2025;7 View